Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Nielsen

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|April 1, 2003
Identification of a cis-element that determines autonomous DNA replication in eukaryotic cellsGerald B Price, Minna Allarakhia, Nandini Cossons, et al.
The Journal of Pathology|September 29, 2011
A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER-positive breast cancerH Raza Ali, Sarah-Jane Dawson, Fiona M Blows, et al.
Oncogene|June 27, 2002
Expression profiling of microdissected pancreatic adenocarcinomasTatjana Crnogorac-Jurcevic, Evangelos Efthimiou, Torsten Nielsen, et al.
BMC Cancer|March 15, 2014
Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimensTorsten Nielsen, Brett Wallden, Carl Schaper, et al.
Journal of the National Cancer Institute|October 31, 2019
Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance)Meenakshi Anurag, Mayanne Zhu, Chen Huang, et al.
Acta Oncologica (Stockholm, Sweden)|November 28, 2017
Intrinsic subtypes and benefit from postmastectomy radiotherapy in node-positive premenopausal breast cancer patients who received adjuvant chemotherapy - results from two independent randomized trialsTinne Laurberg, Trine Tramm, Torsten Nielsen, et al.
The American Journal of Pathology|August 23, 2011
CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesisIñigo Espinosa, Badreddin Edris, Cheng-Han Lee, et al.
BMC Medical Genomics|August 23, 2015
Development and verification of the PAM50-based Prosigna breast cancer gene signature assayBrett Wallden, James Storhoff, Torsten Nielsen, et al.
The Journal of Pathology|July 28, 2011
Using next-generation sequencing for the diagnosis of rare disorders: a family with retinitis pigmentosa and skeletal abnormalitiesKasmintan A Schrader, Alireza Heravi-Moussavi, Paula J Waters, et al.
Seminars in Cancer Biology|October 13, 2017
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerMaria Vittoria Dieci, Nina Radosevic-Robin, Susan Fineberg, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|April 1, 2003
Identification of a cis-element that determines autonomous DNA replication in eukaryotic cellsGerald B Price, Minna Allarakhia, Nandini Cossons, et al.
The Journal of Pathology|September 29, 2011
A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER-positive breast cancerH Raza Ali, Sarah-Jane Dawson, Fiona M Blows, et al.
Oncogene|June 27, 2002
Expression profiling of microdissected pancreatic adenocarcinomasTatjana Crnogorac-Jurcevic, Evangelos Efthimiou, Torsten Nielsen, et al.
BMC Cancer|March 15, 2014
Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimensTorsten Nielsen, Brett Wallden, Carl Schaper, et al.
Journal of the National Cancer Institute|October 31, 2019
Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance)Meenakshi Anurag, Mayanne Zhu, Chen Huang, et al.
Acta Oncologica (Stockholm, Sweden)|November 28, 2017
Intrinsic subtypes and benefit from postmastectomy radiotherapy in node-positive premenopausal breast cancer patients who received adjuvant chemotherapy - results from two independent randomized trialsTinne Laurberg, Trine Tramm, Torsten Nielsen, et al.
The American Journal of Pathology|August 23, 2011
CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesisIñigo Espinosa, Badreddin Edris, Cheng-Han Lee, et al.
BMC Medical Genomics|August 23, 2015
Development and verification of the PAM50-based Prosigna breast cancer gene signature assayBrett Wallden, James Storhoff, Torsten Nielsen, et al.
The Journal of Pathology|July 28, 2011
Using next-generation sequencing for the diagnosis of rare disorders: a family with retinitis pigmentosa and skeletal abnormalitiesKasmintan A Schrader, Alireza Heravi-Moussavi, Paula J Waters, et al.
Seminars in Cancer Biology|October 13, 2017
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerMaria Vittoria Dieci, Nina Radosevic-Robin, Susan Fineberg, et al.
Pageof 4